Search Results 461-470 of 16296 for nivolumab
Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to use genomic and proteomic analyses to identify possible ...
Nivolumab-associated bone marrow necrosis. Ann Oncol 2018 Feb 1; 29 (2):513-514. View PubMed; Hilal T, Fauble V, Ketterling RP, Kelemen K. Myeloid neoplasm ...
... (nivolumab or pembrolizumab) if the tumor has dMMR proteins or is MSI-H. Have progression of unresectable or mCRC after last systemic therapy (as confirmed ...
... (nivolumab) treatment plus platinum doublet chemotherapy. Study of NanoKnife for Ablation of Prostate Cancer in Low and Intermediate Risk Patients Rochester ...
The purpose of this study is to gain stepwise understanding of the fundamental biology governing human antitumor immunity, by systematic study of the tumor- ...
The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...
Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...
About this study. The purpose of these phase I/II trial studies is to analyze the side effects and best dose of liposomal irinotecan and rucaparib when ...
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.